412 related articles for article (PubMed ID: 17763847)
1. Evaluation of invasiveness of astrocytoma using 1H-magnetic resonance spectroscopy: correlation with expression of matrix metalloproteinase-2.
Zhang K; Li C; Liu Y; Li L; Ma X; Meng X; Feng D
Neuroradiology; 2007 Nov; 49(11):913-9. PubMed ID: 17763847
[TBL] [Abstract][Full Text] [Related]
2. In vivo research in astrocytoma cell proliferation with 1H-magnetic resonance spectroscopy: correlation with histopathology and immunohistochemistry.
Chen J; Huang SL; Li T; Chen XL
Neuroradiology; 2006 May; 48(5):312-8. PubMed ID: 16552583
[TBL] [Abstract][Full Text] [Related]
3. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive evaluation of radiation-enhanced glioma cells invasiveness by ultra-high-field (1)H-MRS in vitro.
Xu YJ; Cui Y; Li HX; Shi WQ; Li FY; Wang JZ; Zeng QS
Magn Reson Imaging; 2016 Oct; 34(8):1121-7. PubMed ID: 27215950
[TBL] [Abstract][Full Text] [Related]
5. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging and spectroscopy of pilomyxoid astrocytomas: case reports and comparison with pilocytic astrocytomas.
Morales H; Kwock L; Castillo M
J Comput Assist Tomogr; 2007; 31(5):682-7. PubMed ID: 17895777
[TBL] [Abstract][Full Text] [Related]
7. In vitro study of astrocytic tumour metabolism by proton magnetic resonance spectroscopy.
Likavcanová K; Dobrota D; Liptaj T; Prónayová N; Mlynárik V; Belan V; Galanda M; Béres A; De Riggo J
Gen Physiol Biophys; 2005 Sep; 24(3):327-35. PubMed ID: 16308427
[TBL] [Abstract][Full Text] [Related]
8. In vivo proton magnetic resonance spectroscopy of brain tumors.
Fountas KN; Kapsalaki EZ; Gotsis SD; Kapsalakis JZ; Smisson HF; Johnston KW; Robinson JS; Papadakis N
Stereotact Funct Neurosurg; 2000; 74(2):83-94. PubMed ID: 11251398
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of cerebral glioma grade by using normal side creatine as an internal reference in multi-voxel 1H-MR spectroscopy.
Yerli H; Ağildere AM; Ozen O; Geyik E; Atalay B; Elhan AH
Diagn Interv Radiol; 2007 Mar; 13(1):3-9. PubMed ID: 17354186
[TBL] [Abstract][Full Text] [Related]
10. Proton magnetic resonance spectroscopy of brain tumors correlated with pathology.
Magalhaes A; Godfrey W; Shen Y; Hu J; Smith W
Acad Radiol; 2005 Jan; 12(1):51-7. PubMed ID: 15691725
[TBL] [Abstract][Full Text] [Related]
11. Cho/Cr ratio at MR spectroscopy as a biomarker for cellular proliferation activity and prognosis in glioma: correlation with the expression of minichromosome maintenance protein 2.
Gao W; Wang X; Li F; Shi W; Li H; Zeng Q
Acta Radiol; 2019 Jan; 60(1):106-112. PubMed ID: 29665708
[TBL] [Abstract][Full Text] [Related]
12. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.
Bisdas S; Ritz R; Bender B; Braun C; Pfannenberg C; Reimold M; Naegele T; Ernemann U
Invest Radiol; 2013 May; 48(5):295-301. PubMed ID: 23296081
[TBL] [Abstract][Full Text] [Related]
13. Proton MR spectroscopy of pediatric cerebellar tumors.
Wang Z; Sutton LN; Cnaan A; Haselgrove JC; Rorke LB; Zhao H; Bilaniuk LT; Zimmerman RA
AJNR Am J Neuroradiol; 1995 Oct; 16(9):1821-33. PubMed ID: 8693982
[TBL] [Abstract][Full Text] [Related]
14. Proton magnetic resonance spectroscopic imaging in pediatric pilomyxoid astrocytoma.
Cirak B; Horská A; Barker PB; Burger PC; Carson BS; Avellino AM
Childs Nerv Syst; 2005 May; 21(5):404-9. PubMed ID: 15372294
[TBL] [Abstract][Full Text] [Related]
15. Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging.
Stadlbauer A; Gruber S; Nimsky C; Fahlbusch R; Hammen T; Buslei R; Tomandl B; Moser E; Ganslandt O
Radiology; 2006 Mar; 238(3):958-69. PubMed ID: 16424238
[TBL] [Abstract][Full Text] [Related]
16. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.
Law M; Yang S; Wang H; Babb JS; Johnson G; Cha S; Knopp EA; Zagzag D
AJNR Am J Neuroradiol; 2003; 24(10):1989-98. PubMed ID: 14625221
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive histologic grading of solid astrocytomas using proton magnetic resonance spectroscopy.
Fountas KN; Kapsalaki EZ; Vogel RL; Fezoulidis I; Robinson JS; Gotsis ED
Stereotact Funct Neurosurg; 2004; 82(2-3):90-7. PubMed ID: 15305081
[TBL] [Abstract][Full Text] [Related]
18. Low-grade gliomas and focal cortical developmental malformations: differentiation with proton MR spectroscopy.
Vuori K; Kankaanranta L; Häkkinen AM; Gaily E; Valanne L; Granström ML; Joensuu H; Blomstedt G; Paetau A; Lundbom N
Radiology; 2004 Mar; 230(3):703-8. PubMed ID: 14739313
[TBL] [Abstract][Full Text] [Related]
19. [Clinical application of proton magnetic resonance spectroscopy for differential diagnosis of pediatric posterior fossa tumors].
Zakrzewski K; Kreisel J; Polis L; Nowosławska E; Liberski PP; Biegański T
Neurol Neurochir Pol; 2001; 35 Suppl 5():19-25. PubMed ID: 11935675
[TBL] [Abstract][Full Text] [Related]
20. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
Elias AE; Carlos RC; Smith EA; Frechtling D; George B; Maly P; Sundgren PC
Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]